Target intelligence / Profile preview

CMC1 pseudogene 4 (CMC1P4)

Target: CMC1P4
Molecular classification: Other, Pseudogene

Overview

CMC1 pseudogene 4 (CMC1P4) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a normal gene but typically non-functional due to mutations or lack of regulatory elements required for expression. Pseudogenes do not encode functional proteins, although some can have regulatory roles as long noncoding RNAs in rare cases, such as competing endogenous RNAs (ceRNAs), but no such function is documented for CMC1P4 in current literature or databases[2][3][4]. CMC1P4 is not a therapeutic target (receptor, enzyme, transporter, etc.), lacks any reported involvement in disease, does not interact with drugs, and is not used as a biomarker. There is no evidence of established molecular, biological, or clinical functionality for this pseudogene.

Other names: CMC1P4CMC1 pseudogene 4

Beyond the preview

Go deeper on CMC1 pseudogene 4 (CMC1P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMC1 pseudogene 4 (CMC1P4).

Explore the full profile